| #239 |
Ramona Kei |
IBM |
5 |
| #239 |
Leonard R. Chieco |
IBM |
5 |
| #239 |
Kevin T. Wu |
HP |
5 |
| #239 |
Melissa Heitmann |
Mannkind |
5 |
| #239 |
Vadim Alexandrov |
Pgi Drug Discovery |
5 |
| #239 |
Laurie SZIKLAS |
Emagin |
5 |
| #239 |
Craig R. Gruszecki |
IBM |
5 |
| #239 |
Chung-Ping Eng |
IBM |
5 |
| #239 |
Eric M. Motika |
IBM |
5 |
| #239 |
John A. Trumpetto |
IBM |
5 |
| #239 |
Xia Liu |
Regeneron Pharmaceuticals |
5 |
| #239 |
Corrado P. Mancini |
IBM |
5 |
| #239 |
Robert P. Rippstein |
IBM |
5 |
| #239 |
Jeffrey A. Brody |
IBM |
5 |
| #239 |
Karen Bard |
IBM |
5 |
| #239 |
Kathryn H. Varian |
IBM |
5 |
| #239 |
Edward J. Pega |
IBM |
5 |
| #239 |
Thomas E. Sandwick |
IBM |
5 |
| #239 |
Alan Piciacchio |
IBM |
5 |
| #239 |
Kurt R. Muller |
IBM |
5 |
| #239 |
Karl-Heinz Froehner |
Siemens Aktiengesellschaft |
5 |
| #239 |
Joyce Elizabeth Acocella |
IBM |
5 |
| #239 |
Fred Tze-Keung Tong |
IBM |
5 |
| #239 |
Bob H. Yun |
IBM |
5 |
| #239 |
Javathu K. Hassan |
IBM |
5 |
| #239 |
Homi G. Sarkary |
IBM |
5 |
| #239 |
Janos Havas |
IBM |
5 |
| #239 |
Albert Amendola |
IBM |
5 |
| #279 |
Shantha Kumar |
Sterlite Technologies Limited |
4 |
| #279 |
Robert Willem Van Den Berg |
IBM |
4 |
| #279 |
Hans B. Pogge |
IBM |
4 |
| #279 |
Frank Findeis |
IBM |
4 |
| #279 |
William L. Lafferty, Jr. |
Chevron |
4 |
| #279 |
Peter Berasi |
IBM |
4 |
| #279 |
Ahmet Bindal |
IBM |
4 |
| #279 |
Louis J. Bosch |
IBM |
4 |
| #279 |
Joe Quock |
Uop |
4 |
| #279 |
Robert D. Teter |
Safe Flight Instrument |
4 |
| #279 |
Douglas D. DeMasi |
— |
4 |
| #279 |
Bret G. Bidwell |
IBM |
4 |
| #279 |
Chunyan E. Tian |
IBM |
4 |
| #279 |
Louis V. Medina |
IBM |
4 |
| #279 |
Cheruvu Murthy |
IBM |
4 |
| #279 |
David Wa-Wai Nip |
IBM |
4 |
| #279 |
Douglas J. DeYoung |
S. C. Johnson Commercial Markets |
4 |
| #279 |
James Basso |
AT&T |
4 |
| #279 |
John F. Canale |
IBM |
4 |
| #279 |
Rod Augur |
Globalfoundries |
4 |
| #279 |
Srinivasan Rangarajan |
IBM |
4 |
| #279 |
Mark N. Jobes |
Cbn Nano Technologies |
4 |